Drugs Made In America Acquisition II (DMII) vs General Catalyst Global Resilience Merger (GCGR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Drugs Made In America Acquisition II is the larger company by market cap ($649.1 million vs $467.9 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | DMII | GCGR |
|---|---|---|
| Share price | $10.19 | $10.13 |
| Market cap | $649.10M | $467.87M |
| 1-day change | 0.00% | 0.00% |
| P/E ratio (TTM) | 33.97 | — |
| EPS (TTM) | $0.30 | — |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.33 | $10.22 |
| 52-week low | $9.86 | $9.96 |
| Distance from 52-week high | -1.36% | -0.88% |
| Average volume | 57.23K | 41.09K |
| Shares outstanding | 63.70M | 41.16M |
| Sector | Finance | Financial Services |
| Industry | Blank Checks | Shell Companies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Drugs Made In America Acquisition II in Finance and General Catalyst Global Resilience Merger in Financial Services.
About Drugs Made In America Acquisition II
DMII stock →Drugs Made In America Acquisition II Corp. does not have significant operations.
Finance · Blank Checks
About General Catalyst Global Resilience Merger
GCGR stock →General Catalyst Global Resilience Merger Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
Financial Services · Shell Companies
DMII vs GCGR FAQ
Which is bigger, Drugs Made In America Acquisition II or General Catalyst Global Resilience Merger?
Drugs Made In America Acquisition II (DMII) is larger, with a market capitalization of $649.10M compared with $467.87M for General Catalyst Global Resilience Merger (GCGR).
Are Drugs Made In America Acquisition II and General Catalyst Global Resilience Merger in the same industry?
No. Drugs Made In America Acquisition II is in the Finance sector, while General Catalyst Global Resilience Merger is in Financial Services.